New device promises reliable rehabilitation for balance disorders

The University of the Basque Country (UPV/EHU) has presented a promising device designed to conduct measurements reliably and repeatably when treating the after-effects of stroke, vertigo, etc.

The UPV/EHU's COMPMECH research group has patented a mechatronic instrument that uses a mobile platform to stimulate the patient's balance in a controlled manner and measures his/her response. This prototype, which enables rehabilitation work to be systematized while monitoring the patient's evolution over time, is the result of close collaboration with professionals from different departments at Gorliz Hospital.

One of the main sequelae of stroke is partial loss of strength or partial paralysis. This condition means that patients who have suffered a stroke must undergo long rehabilitation processes to recover their balance and gait. The traditional techniques used in exercise-based assessments are not entirely objective, as they largely depend on the person carrying them out. So professionals from Gorliz Hospital suggested a need to objectify this assessment and systematize the evolution of patients during the rehabilitation process.

So the UPV/EHU's COMPMECH research group, which has expertise in mechatronics (a multidisciplinary branch of engineering that develops devices and technologies combining the branches of systems, electronics, mechanics, control and robotics), has developed a new prototype to "assess, exercise and rehabilitate a person's balance when standing on a surface by measuring his or her centre of pressure," explained Francisco Campa, a researcher in the group.

"Let's imagine we are standing while travelling on a bus," explained Campa. "When the bus moves off or brakes, the body, in order to balance itself, distributes its weight forwards and backwards supported by the soles of the feet against the floor. The resultant point of this force is known as the centre of pressure, and the study of its movement enables a person's balance to be assessed."

Control over balance stimulation

The prototype recently patented by the COMPMECH group has a platform on which the person with balance problems stands, and has two functions. The first is to stimulate the patient's balance, in other words, to provoke a reaction in order to see how he or she responds. "The mechanism we have designed raises the platform vertically or tilts it forward, from side to side or in any direction, with a certain amplitude and speed that is determined by the physiotherapist who is programming the machine," he pointed out. And the second function is to measure the patient's response: "The platform rests on four sensors that enable the force the patient is exerting on the platform to be measured. And on the basis of that force, the movement of the centre of pressure is determined," he added.

What is new about this prototype is that "it has been designed to make reliable and repeatable measurements. The same stimulus is always introduced. It is always going to be a movement of a certain amplitude and speed, so that it can be better traced, and the patient's evolution can be better monitored over time. This allows us to be more effective in finding out what has caused the patient to move in a certain way," he pointed out.

Once the design had been validated by the medical team at Gorliz Hospital, the prototype entered the clinical trial phase: "We have started testing the prototype on actual patients and volunteers," said Campa. The researcher pointed out that "this machine is promising, because balance problems are not only experienced by stroke patients, but also by patients with other conditions, such as amputees who need to get used to a prosthesis, people with vertigo problems, etc."

Campa is delighted with the level of collaboration they have had with the team of professionals at Gorliz Hospital: "Their involvement has been invaluable. They have opened the doors of the hospital to us, and we have worked side by side with professionals from many different fields."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Retinal vascular features identified as potential predictors of stroke risk